Assembly Biosci 
Welcome,         Profile    Billing    Logout  
 4 Products   0 Diseases  4 Products   3 Trials   175 News 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABI-H2158 / Assembly Biosci
2019-004902-85: Study Evaluating ABI-H2158-Containing Regimens in Chronic Hepatitis B Infection

Not yet recruiting
2
80
Europe
ABI-H2158, ABI-H2158, Film-coated tablet
Assembly Biosciences, Assembly Biosciences
Chronic Hepatitis B Infection, A serious liver infection caused by the hepatitis B virus., Diseases [C] - Virus Diseases [C02]
 
 
vebicorvir (ABI-H0731) / Assembly Biosci
2018-002042-36: A study to test ABI-H0731 with Entecavir to treat patients with Chronic Hepatitis B

Not yet recruiting
2
20
Europe
ABI-H0731, Entecavir USP, Tablet, Entecavir USP
Assembly Biosciences, Assembly Biosciences
Chronic Hepatitis B, A serious liver viral infection, Diseases [C] - Virus Diseases [C02]
 
 
NCT04820686: A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection

Terminated
2
65
Europe, Canada, RoW
VBR, Vebicorvir, ABI-H0731, AB-729, SOC NrtI, Entecavir (ETV), Tenofovir disoproxil fumarate (TDF), Tenofovir alafenamide (TAF)
Assembly Biosciences, Arbutus Biopharma Corporation
Chronic Hepatitis B
03/23
03/23
2020-005766-34: A Randomized Phase 2a, Multicenter, Open-Label, Multiple-Cohort Study Evaluating Regimens Containing Vebicorvir in Subjects with Chronic Hepatitis B Virus Infection

Not yet recruiting
2
180
Europe
Vebicorvir, AB-729, ABI-H0731, AB-729, Tablet, Solution for injection
Assembly Biosciences, Inc., Assembly Biosciences, Inc.
Chronic Hepatitis B Virus Infection, Chronic Hepatitis B Virus Infection, Diseases [C] - Virus Diseases [C02]
 
 
ABI-H3733 / Assembly Biosci, BeOne Medicines
NCT05414981: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

Completed
1b
31
Europe, RoW
ABI-H3733, Placebo
Assembly Biosciences
Chronic Hepatitis B
04/23
04/23
ABI-4334 / Assembly Biosci
NCT05569941: A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

Completed
1
54
RoW
ABI-4334 Tablet, ABI-4334 Placebo
Assembly Biosciences
Chronic Hepatitis B
04/23
04/23
NCT06384131: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection

Completed
1
20
RoW
ABI-4334, Placebo
Assembly Biosciences
Chronic Hepatitis B
04/25
05/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABI-H2158 / Assembly Biosci
2019-004902-85: Study Evaluating ABI-H2158-Containing Regimens in Chronic Hepatitis B Infection

Not yet recruiting
2
80
Europe
ABI-H2158, ABI-H2158, Film-coated tablet
Assembly Biosciences, Assembly Biosciences
Chronic Hepatitis B Infection, A serious liver infection caused by the hepatitis B virus., Diseases [C] - Virus Diseases [C02]
 
 
vebicorvir (ABI-H0731) / Assembly Biosci
2018-002042-36: A study to test ABI-H0731 with Entecavir to treat patients with Chronic Hepatitis B

Not yet recruiting
2
20
Europe
ABI-H0731, Entecavir USP, Tablet, Entecavir USP
Assembly Biosciences, Assembly Biosciences
Chronic Hepatitis B, A serious liver viral infection, Diseases [C] - Virus Diseases [C02]
 
 
NCT04820686: A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection

Terminated
2
65
Europe, Canada, RoW
VBR, Vebicorvir, ABI-H0731, AB-729, SOC NrtI, Entecavir (ETV), Tenofovir disoproxil fumarate (TDF), Tenofovir alafenamide (TAF)
Assembly Biosciences, Arbutus Biopharma Corporation
Chronic Hepatitis B
03/23
03/23
2020-005766-34: A Randomized Phase 2a, Multicenter, Open-Label, Multiple-Cohort Study Evaluating Regimens Containing Vebicorvir in Subjects with Chronic Hepatitis B Virus Infection

Not yet recruiting
2
180
Europe
Vebicorvir, AB-729, ABI-H0731, AB-729, Tablet, Solution for injection
Assembly Biosciences, Inc., Assembly Biosciences, Inc.
Chronic Hepatitis B Virus Infection, Chronic Hepatitis B Virus Infection, Diseases [C] - Virus Diseases [C02]
 
 
ABI-H3733 / Assembly Biosci, BeOne Medicines
NCT05414981: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

Completed
1b
31
Europe, RoW
ABI-H3733, Placebo
Assembly Biosciences
Chronic Hepatitis B
04/23
04/23
ABI-4334 / Assembly Biosci
NCT05569941: A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

Completed
1
54
RoW
ABI-4334 Tablet, ABI-4334 Placebo
Assembly Biosciences
Chronic Hepatitis B
04/23
04/23
NCT06384131: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection

Completed
1
20
RoW
ABI-4334, Placebo
Assembly Biosciences
Chronic Hepatitis B
04/25
05/25

Download Options